Portfolio
Business development opportunities

EUSA Pharma is seeking to in-license oncology, pain control and critical care products currently in phase III for its target markets in Europe and North America in the following areas – Oncology, Pain and Critical Care.  

In addition, EUSA is divesting a series of revenue generating non core assets, and development stage assets..

All Business development opportunities and enquiries should be directed to: Anuj.Madhok@eusapharma.com